Navigation Links
CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
Date:2/15/2012

PRINCETON, New Jersey, February 15, 2012 /PRNewswire/ --

CitiusTech, a leading healthcare technology solution provider, announced that it has completed the calendar year 2011 with 59% growth in revenues. 2011 is now the fifth consecutive year that CitiusTech has recorded over 50% Y-o-Y revenue growth. In 2011, CitiusTech won the Red Herring Award for leadership in healthcare technology. CitiusTech was selected as a finalist at the 2011 American Business Awards for being one of the fastest growing technology companies in the United States.

Growth in 2011 has been driven by existing customer relationships (93% customer retention) and by new customer additions across North America and Europe.  CitiusTech also enhanced its capabilities across its key service offerings - software product engineering, professional services and healthcare BI/analytics. CitiusTech's BI-Clinical platform became the only modular BI solution to be ONC-ATCB 2011/2012 certified for all Eligible Hospital (EH) and Eligible Professional (EP) Meaningful Use Clinical Quality Measures. BI-Clinical was also one of the first BI/analytics platforms to comply with all 33 ACO quality measures that were released by CMS.

During 2011, CitiusTech's software engineering practice enabled many leading healthcare IT vendors to enhance and architect their solutions (e.g., for mobile and cloud computing) and comply with new technology and regulatory needs (including Meaningful Use, ACO etc.). In addition, CitiusTech professional services team formed strategic partnerships with HIE, EMR and clinical application organizations to help them scale their professional services organizations worldwide. With over 250 HL7 certified professionals, CitiusTech retains the distinction of having the largest number of certified interoperability professionals worldwide. CitiusTech also expanded its reach, with new offices in Princeton NJ, Singapore and India.

"2011 has been an excellent year for CitiusTech. Our ability to form and grow long-term partnerships with healthcare technology organizations and support their business growth has been key to our success," said Rizwan Koita, CEO, CitiusTech. "Our BI-Clinical platform has been strongly received by our partners for population health management, care coordination and quality reporting."

About CitiusTech

CitiusTech is a specialist provider of healthcare technology services and solutions to healthcare IT vendors, providers, ACOs,and health plans. CitiusTech offers a wide range of healthcare technology services including healthcare software development, healthcare interoperability, Meaningful Use compliance, BI /analytics, care management and consumer health.

CitiusTech's BI-Clinical platform is s market leader in healthcare BI/ analytics. CitiusTech brings strong healthcare expertise across technologies, applications and standards. Our ability to providethis expertise, together with world-class service quality and aglobal resource base, enables us to deliver best-in- class solutions and an unmatched cost advantage to healthcare clients worldwide.


For further information:
CitiusTech Inc.
Sujay Pal
Manager - Corporate Marketing
sujay.pal@citiustech.com
+1-877-248-4871



'/>"/>
SOURCE CitiusTech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
4. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
7. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
8. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
9. Roche completes acquisition of ARIUS
10. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
11. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the only free validated ... will showcase its product’s latest features from June 26 to June 30, 2016 ... on Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug ...
(Date:6/23/2016)... ... June 23, 2016 , ... Velocity Products, a division of ... and optimized exclusively for Okuma CNC machining centers at The International Manufacturing Technology ... among several companies with expertise in toolholding, cutting tools, machining dynamics and distribution, ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
Breaking Biology News(10 mins):